Literature DB >> 33046336

Childhood schizotypal features vs. high-functioning autism spectrum disorder: Developmental overlaps and phenomenological differences.

Michele Poletti1, Andrea Raballo2.   

Abstract

Although autism spectrum disorder and schizophrenia have allegedly different onset timelines (e.g. in early years of life vs adolescence/early adulthood), there is nonetheless a diagnostic grey-zone along developmental stages, in which overlapping clinical features related to social impairment and oddity could impact on the differential diagnosis between childhood schizotypal features and high-functioning autism spectrum disorder. A phenomenological perspective may be helpful for the purpose of timely differential diagnosis also in developmental years.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Childhood schizotypal features; High-functioning autism; Oddity; Psychosis; Social impairment

Mesh:

Year:  2020        PMID: 33046336     DOI: 10.1016/j.schres.2020.09.027

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  3 in total

1.  Clinical high risk for psychosis paradigm for CAP: do not throw the baby out with the bathwater.

Authors:  Paul Klauser; Alexis Revet; Dimitri Anagnostopoulos; Johannes Hebebrand; Carmen Moreno; Jean-Philippe Raynaud; Marco Armando
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-08-24       Impact factor: 4.785

2.  Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe.

Authors:  Christoph U Correll; Paolo Fusar-Poli; Stefan Leucht; Anne Karow; Nadja Maric; Carmen Moreno; Merete Nordentoft; Andrea Raballo
Journal:  Neuropsychiatr Dis Treat       Date:  2022-02-09       Impact factor: 2.570

3.  The Relationship Between Affective Visual Mismatch Negativity and Interpersonal Difficulties Across Autism and Schizotypal Traits.

Authors:  Talitha C Ford; Laila E Hugrass; Bradley N Jack
Journal:  Front Hum Neurosci       Date:  2022-03-23       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.